Growth Metrics

Inspire Medical Systems (INSP) Cash from Financing Activities (2017 - 2026)

Inspire Medical Systems' Cash from Financing Activities history spans 10 years, with the latest figure at -$7.5 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 91.47% to -$7.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$103.2 million, a 26.79% increase, with the full-year FY2025 number at -$183.4 million, down 250.14% from a year prior.
  • Cash from Financing Activities hit -$7.5 million in Q1 2026 for Inspire Medical Systems, up from -$48.3 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for INSP hit a ceiling of $224.1 million in Q3 2022 and a floor of -$87.8 million in Q1 2025.
  • Historically, Cash from Financing Activities has averaged $335470.6 across 5 years, with a median of $3.0 million in 2022.
  • Biggest five-year swings in Cash from Financing Activities: surged 5732.03% in 2022 and later tumbled 11527.08% in 2025.
  • Tracing INSP's Cash from Financing Activities over 5 years: stood at $7.3 million in 2022, then crashed by 238.77% to -$10.1 million in 2023, then crashed by 593.41% to -$70.1 million in 2024, then skyrocketed by 31.12% to -$48.3 million in 2025, then surged by 84.51% to -$7.5 million in 2026.
  • Business Quant data shows Cash from Financing Activities for INSP at -$7.5 million in Q1 2026, -$48.3 million in Q4 2025, and -$51.1 million in Q3 2025.